|
|
| ||
| freemexy |
| ||
| Edecrin (ethacrynic acid) is a loop diuretic (water pill) used to treat
fluid retention (edema) in people with congestive heart failure, liver
disease, or a kidney disorder such as nephrotic syndrome. Common side
effects of Edecrin include:wisepoqder Ethacrynic acid
Using too much Edecrin can lead to serious water and mineral loss (dehydration). Tell your doctor if you have unlikely but serious symptoms of dehydration including loss of appetite, confusion, severe dizziness, fainting, unusual dry mouth, thirst, severe headache, fast or irregular heartbeat, muscle cramps or spasms, nausea, vomiting, numbness and tingling, seizure, decrease in amount of urine, or unusual weakness or tiredness. The smallest dose of Edecrin should be given to produce gradual weight loss (about 1 to 2 pounds per day). Onset of diuresis usually occurs at 50 to 100 mg for adults. After diuresis has been achieved, the minimally effective dose (usually from 50 to 200 mg daily) may be given on a continuous or intermittent dosage schedule. Edecrin may interact with lithium, digoxin, blood thinners, other diuretics, steroids, cancer medicines, cephalosporin antibiotics, aspirin and other salicylates, NSAIDs (nonsteroidal anti-inflammatory drugs), amikacin, gentamicin, netilmicin, streptomycin, or tobramycin. During pregnancy, Edecrin should be used only when prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding. Our Edecrin (ethacrynic acid) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. | ||
| 0 Commentaires | poster un commentaire | Lien Permanent |
| ||
| Indian Pharma major Lupin Limited (Lupin) on 9 Sep 2019, announced that
it has received approval for its Ethacrynic Acid Tablets USP, 25 mg,
from the United States Food and Drug Administration (U.S. FDA).wisepoqder Ethacrynic acid powder
Lupin’s Ethacrynic Acid Tablets USP, 25 mg, is the generic version of Edecrin® Tablets, 25 mg, of Bausch Health Americas, Inc. It is indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. Treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. Short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. Intravenous ethacrynic acid sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or oral medication is not practicable. Ethacrynic Acid Tablets USP had annual sales of approximately USD 24 million in the US (IQVIA MAT June 2019). Lupin announced that it has received approval for its Ethacrynic Acid Tablets USP, 25 mg, from the United States Food and Drug Administration (USFDA).Lupin's Ethacrynic Acid Tablets USP, 25 mg, is the generic version of Edecrin Tablets, 25 mg, of Bausch Health Americas, Inc.Ethacrynic Acid Tablets USP (RLD: Edecrin Tablets) had annual sales of approximately USD 24 million in the US (IQVIA MAT June 2019). | ||
| 0 Commentaires | poster un commentaire | Lien Permanent |
| Page 213 of 834 |
| Précédent | Suivant |